Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J de Champlain

Showing results (101-110 of 202) with videos related to

Pageof 21
Sort By:
Canadian Journal of Physiology and Pharmacology|June 1, 1977
Blood and plasma volume changes in dogs after sympathectomy with 6-hydroxydopamineG A Porlier, R A Nadeau, J de Champlain
The American Journal of Physiology|May 1, 1997
Canine adrenal catecholamine response to VIP is blocked by PACAP-(6-27) in vivoR Gaspo, L Lamarche, J de Champlain, et al.
Expert Opinion on Investigational Drugs|January 5, 2002
Therapeutic potential of angiotensin II receptor antagonistsM White, N Racine, A Ducharme, et al.
The American Journal of Physiology|July 1, 1993
Presynaptic effects of epinephrine on norepinephrine release from cardiac sympathetic nerves in dogsG Boudreau, F Péronnet, J De Champlain, et al.
Canadian Journal of Physiology and Pharmacology|September 1, 1982
Plasma catecholamines and response to exercise in 6-hydroxydopamine-treated dogsF Péronnet, R Nadeau, J de Champlain, et al.
European Journal of Pharmacology|September 4, 1991
Regulation of cardiovascular sympathetic neurons by substance P and gamma-aminobutyric acid in the rat spinal cordH Hasséssian, A Prat, J De Champlain, et al.
The American Journal of Physiology|August 1, 1978
Sequential changes in catecholamine plasma levels during isotonic volume expansion in dogsS Carrière, G Lalumière, A Daigneault, et al.
Canadian Journal of Physiology and Pharmacology|January 29, 1999
Role of NO and angiotensin II in the early development of endothelial functions impairment and cardiac hypertrophy in deoxycorticosterone acetate-salt hypertensionA K-Laflamme, L Oster, R Cardinal, et al.
Canadian Journal of Physiology and Pharmacology|December 1, 1993
Effect of increases in myocardial epinephrine content on epinephrine release from the dog heartF Péronnet, G Boudreau, J de Champlain, et al.
European Heart Journal|January 1, 1993
Paradoxical decrease in circulating neuropeptide Y-like immunoreactivity during mild orthostatic stress in subjects with and without congestive heart failureG Derchi, J Dupuis, J de Champlain, et al.
Pageof 21

Showing results (101-110 of 202) with videos related to

Sort By:
Pageof 21
Canadian Journal of Physiology and Pharmacology|June 1, 1977
Blood and plasma volume changes in dogs after sympathectomy with 6-hydroxydopamineG A Porlier, R A Nadeau, J de Champlain
The American Journal of Physiology|May 1, 1997
Canine adrenal catecholamine response to VIP is blocked by PACAP-(6-27) in vivoR Gaspo, L Lamarche, J de Champlain, et al.
Expert Opinion on Investigational Drugs|January 5, 2002
Therapeutic potential of angiotensin II receptor antagonistsM White, N Racine, A Ducharme, et al.
The American Journal of Physiology|July 1, 1993
Presynaptic effects of epinephrine on norepinephrine release from cardiac sympathetic nerves in dogsG Boudreau, F Péronnet, J De Champlain, et al.
Canadian Journal of Physiology and Pharmacology|September 1, 1982
Plasma catecholamines and response to exercise in 6-hydroxydopamine-treated dogsF Péronnet, R Nadeau, J de Champlain, et al.
European Journal of Pharmacology|September 4, 1991
Regulation of cardiovascular sympathetic neurons by substance P and gamma-aminobutyric acid in the rat spinal cordH Hasséssian, A Prat, J De Champlain, et al.
The American Journal of Physiology|August 1, 1978
Sequential changes in catecholamine plasma levels during isotonic volume expansion in dogsS Carrière, G Lalumière, A Daigneault, et al.
Canadian Journal of Physiology and Pharmacology|January 29, 1999
Role of NO and angiotensin II in the early development of endothelial functions impairment and cardiac hypertrophy in deoxycorticosterone acetate-salt hypertensionA K-Laflamme, L Oster, R Cardinal, et al.
Canadian Journal of Physiology and Pharmacology|December 1, 1993
Effect of increases in myocardial epinephrine content on epinephrine release from the dog heartF Péronnet, G Boudreau, J de Champlain, et al.
European Heart Journal|January 1, 1993
Paradoxical decrease in circulating neuropeptide Y-like immunoreactivity during mild orthostatic stress in subjects with and without congestive heart failureG Derchi, J Dupuis, J de Champlain, et al.
Pageof 21